RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+6.66%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$328M
AUM Growth
+$328M
(+31%)
Cap. Flow
+$74.7M
Cap. Flow
% of AUM
22.76%
Top 10 Holdings %
Top 10 Hldgs %
36.15%
Holding
103
New
20
Increased
33
Reduced
37
Closed
13
Top Buys
| 1 |
Pfizer
PFE
|
$11.3M |
| 2 |
Gilead Sciences
GILD
|
$9.9M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.39M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.73M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$5.64M |
Top Sells
| 1 |
Innoviva
INVA
|
$4.71M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$3.73M |
| 3 |
Intuitive Surgical
ISRG
|
$3.07M |
| 4 |
Zimmer Biomet
ZBH
|
$2.8M |
| 5 |
AET
Aetna Inc
AET
|
$2.74M |
Sector Composition
| 1 | Healthcare | 80.94% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $17.6M | 5.29% | 248,735 +139,735 | +128% | +$9.9M |
|
|
ALXN
2
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $17M | 5.1% | 111,731 +61,731 | +123% | +$9.39M |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $16.8M | 5.03% | 55,792 +18,792 | +51% | +$5.64M |
|
4
Biogen
BIIB
$19.4B
| $12.6M | 3.77% | 41,048 +14,048 | +52% | +$4.3M |
|
|
5
Pfizer
PFE
$141B
| $11.3M | 3.4% | +352,989 | New | +$11.3M |
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $9.91M | 2.97% | 145,264 +45,264 | +45% | +$3.09M |
|
|
PCYC
7
DELISTED
PHARMACYCLICS INC
PCYC
| $9.75M | 2.93% | 97,286 +37,286 | +62% | +$3.74M |
|
8
Alkermes
ALKS
$4.78B
| $8.87M | 2.66% | 201,277 +56,277 | +39% | +$2.48M |
|
|
CELG
9
DELISTED
Celgene Corp
CELG
| $8.15M | 2.45% | 58,391 +9,391 | +19% | +$1.31M |
|
|
MDVN
10
DELISTED
MEDIVATION, INC.
MDVN
| $6.73M | 2.02% | +104,505 | New | +$6.73M |
|
11
CVS Health
CVS
$92.8B
| $6.62M | 1.99% | 88,442 -18,558 | -17% | -$1.39M |
|
12
Incyte
INCY
$16.5B
| $5.73M | 1.72% | 107,038 +22,038 | +26% | +$1.18M |
|
13
Teva Pharmaceuticals
TEVA
$21.1B
| $5.7M | 1.71% | 107,922 +42,922 | +66% | +$2.27M |
|
|
SLXP
14
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $5.57M | 1.67% | 53,788 -1,212 | -2% | -$126K |
|
|
CFNL
15
DELISTED
Cardinal Financial Corp
CFNL
| $5.03M | 1.51% | +71,909 | New | +$5.03M |
|
|
NPSP
16
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $5M | 1.5% | 166,970 -73,030 | -30% | -$2.19M |
|
|
KERX
17
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $4.52M | 1.36% | 265,325 -134,675 | -34% | -$2.29M |
|
|
FRX
18
DELISTED
FOREST LABORATORIES INC
FRX
| $4.44M | 1.33% | 48,152 -6,848 | -12% | -$632K |
|
19
AbbVie
ABBV
$372B
| $4.39M | 1.32% | +85,494 | New | +$4.39M |
|
20
Merck
MRK
$210B
| $4.35M | 1.31% | 76,650 -8,350 | -10% | -$474K |
|
21
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.3M | 1.29% | 176,883 +91,883 | +108% | +$2.24M |
|
22
Stryker
SYK
$150B
| $4.16M | 1.25% | +51,100 | New | +$4.16M |
|
|
CYBX
23
DELISTED
CYBERONICS INC
CYBX
| $4.16M | 1.25% | 63,754 +23,754 | +59% | +$1.55M |
|
24
Thermo Fisher Scientific
TMO
$186B
| $4.14M | 1.24% | 34,394 +9,394 | +38% | +$1.13M |
|
25
Cigna
CI
$80.3B
| $4.11M | 1.23% | 49,135 +22,135 | +82% | +$1.85M |
|